Emerging-Biotech Open to everyone
Embed:
Loading Portfolio...
| id | rsymbol | Symbol | Current Price | Change (%) | Open | High | Low | Volume | Date Added | Cost per share | Quantity | Value | Value Weighting | Gain (%) | Gain ($) | Fair Value ($) | Note | Company | Exchange | Industry | Market Cap ($M) | Sales ($M) | Book Value | Debt to Equity | Yield | Payout | 10-Y Dividend Payout Range | Financial Strength | Profitability | Interest Coverage | 52-W Range | 1-W Change (%) | 4-W Change (%) | 52-W Change (%) | YTD Change (%) | Beta | Short Ratio | P/E | P/S | P/B | 10-Year P/E Range | 10-Year P/S Range | 10-Year P/B Range | PEG | 1-Year Revenue Growth Rate | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | 1-Year EBITDA Growth Rate | 5-Year EBITDA Growth Rate | 10-Year EBITDA Growth Rate | NCAV | Median PS Value | Graham Number | Peter Lynch Fair Value | Earnings Yield | Forward Rate of Return | Shiller P/E | EV/EBIT | EV/EBITDA | Predictability Rank | Operating Margin | Net Margin | Cash per Share | ROE | ROA | Altman Z Score | Piotroski F Score | Beneish M Score | EV/Sales |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 484640 | TGTX | TGTX | 5.65 | -0.05 (-0.88%) | 5.71 | 5.72 | 5.60 | 19K | 03/12/2013 | 4.02 | 0 | 0.00 | 0% | 40.55% | 0.00 | Add | TG Therapeutics Inc | OTCBB(USA) | Market Overview | 150.039 | 0.06 | 0.6 | 0 | 0.00 | 0 | 53.8 | 26.4 | 0 | 1.82 6.75 |
1.99 | -5.83 | -8.87 | 55.22 | 0 | 0 | 0.00 | 1666.67 | 9.50 | 0.01 10 |
0.01 9.6 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.00 | 0 | 0 | 11.4 | -17.74 |
Not Rated
Top Ranked Predictable Companies
|
-141552.60 | -95121.1 | 0.39 | -116.2 | -81.9 | 11.28 | 2 | -1.66 | 201.44 | |||
| 483494 | ALNY | ALNY | 28.03 | 0.47 (1.71%) | 27.56 | 28.23 | 27.38 | 212K | 03/09/2013 | 24.47 | 0 | 0.00 | 0% | 14.55% | 0.00 | Add | Alnylam Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 1713.43 | 64.78 | 2.17 | 0 | 0.00 | 0 | 65.4 | 20.7 | 10000 | 9.78 28.68 |
0.14 | 19.74 | 178.35 | 53.59 | 1.18 | 972 | 0.00 | 23.15 | 13.00 | 3.09 10 |
0.55 10 |
0 | -36.1 | -12.6 | 46.1 | 0 | 36.6 | -5.6 | -0.01 | 17.76 | 0 | -34.39 | 0.00 | 17.13 | 0 | 9.7 | -12.20 |
Not Rated
Top Ranked Predictable Companies
|
-194.00 | -158.9 | -0.5 | -79.1 | -36.9 | 4.86 | 2 | -3.66 | 3.64 | |||
| 483479 | RXII | RXII | 0.20 | - | 0.19 | 0.20 | 0.19 | 337K | 03/09/2013 | 0.20 | 0 | 0.00 | 0% | 0% | 0.00 | Add | RXi Pharmaceuticals Corp | OTCBB(USA) | Market Overview | 67.6308 | 0.1 | -0.0873 | 0 | 0.00 | 0 | 0 | 0 | 10000 | 0.05 0.3 |
2.3 | -31.03 | 81.82 | 166.67 | 0 | 0 | 0.00 | 232.56 | 0.00 | 0 10 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0.00 | 0 | 0 | 10.8 | 0.00 |
Not Rated
Top Ranked Predictable Companies
|
-13376.30 | -13278.4 | 0 | 0 | -230.3 | 0 | 0 | 0 | 196.41 | ||||
| 469197 | ACHN | ACHN | 7.75 | 0.20 (2.65%) | 7.57 | 7.83 | 7.50 | 1.2M | 02/16/2013 | 9.81 | 0 | 0.00 | 0% | -21% | 0.00 | Add | Achillion Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 729.003 | 0.12 | 0.9 | 0 | 0.00 | 0 | 73.1 | 28.9 | 10000 | 5.42 11.36 |
6.16 | 4.73 | 7.49 | -3.25 | 0.75 | 1138 | 0.00 | 5000.00 | 8.50 | 0 5.64 |
0.78 10 |
0.65 10 |
0 | 33.3 | 0 | 0 | 0 | -16.9 | 0 | 0.01 | 5.03 | 0 | 0 | 286.70 | -41.16 | 5.3 | 0.3 | -28.91 |
Not Rated
Top Ranked Predictable Companies
|
-1814.10 | -1807.7 | 0.71 | -65.4 | -57.8 | 41.55 | 0 | 35.46 | 1203.18 | ||
| 469198 | AGEN | AGEN | 4.01 | -0.13 (-3.14%) | 4.11 | 4.16 | 4.00 | 149K | 02/16/2013 | 4.35 | 0 | 0.00 | 0% | -7.82% | 0.00 | Add | Agenus, Inc. | NAS(USA) | Biotechnology | 117.183 | 3.7 | -0.92 | -1.57 | 0.00 | 0 | 23.1 | 55.4 | 0 | 3.37 5.99 |
-8.86 | -6.74 | -28.39 | -2.2 | 1.91 | 1041 | 0.00 | 26.39 | 0.00 | 4.61 10 |
0 10 |
0 | -78.6 | 15.3 | 6.2 | 0 | -45.5 | -32.2 | -0.04 | 6.69 | 0 | 0 | 670.10 | -73.43 | 0 | 0.1 | -7.79 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-42.20 | -71 | -1.21 | 0 | -38.9 | -34.82 | 1 | 14.92 | -5.17 | |||
| 469199 | BLRX | BLRX | 1.75 | -0.03 (-1.69%) | 1.78 | 1.78 | 1.74 | 50.1K | 02/16/2013 | 3.93 | 0 | 0.00 | 0% | -55.47% | 0.00 | Add | Bioline Rx Ltd. | NAS(USA) | Biotechnology | 39.6146 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0 | 1.59 5.1 |
-2.78 | -4.37 | -27.69 | -30.83 | 0 | 39 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0.00 | 0 | 0 | 250 | 0.00 |
Not Rated
Top Ranked Predictable Companies
|
0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| 469200 | IDIX | IDIX | 4.07 | 0.01 (0.25%) | 4.06 | 4.14 | 3.98 | 365K | 02/16/2013 | 4.68 | 0 | 0.00 | 0% | -13.03% | 0.00 | Add | Idenix Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 543.874 | 69.66 | 1.63 | 0.21 | 0.00 | 0 | 80.8 | 43 | 10000 | 3.21 11.3 |
11.51 | 7.11 | -51.08 | -16.08 | 0.33 | 1297 | 0.00 | 14.62 | 2.60 | 0 50 |
1.86 10 |
1.28 10 |
0 | 625 | 21.4 | -24 | 0 | -24.4 | -5.1 | 0.02 | 8.04 | 0 | 0 | 0.00 | -44.78 | 0 | 11.9 | -9.82 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-50.80 | -46.5 | 1.48 | -14.8 | -12.9 | 6.85 | 3 | -3.16 | 2.95 | ||
| 469201 | INO | INO | 0.71 | 0.03 (4.35%) | 0.67 | 0.72 | 0.67 | 2.7M | 02/16/2013 | 0.73 | 0 | 0.00 | 0% | -2.74% | 0.00 | Add | Inovio Pharmaceuticals, Inc. | AMEX(USA) | Biotechnology | 122 | 3.88 | 0.19 | 0 | 0.00 | 0 | 52.3 | 29.8 | 10000 | 0.38 0.83 |
7.2 | 25.22 | 54.48 | 41.64 | 2.71 | 95 | 0.00 | 25.84 | 3.80 | 1.51 10 |
0.38 10 |
0 | -50 | -13.3 | 1.4 | 0 | -11.2 | -16.2 | 0.00 | 0.35 | 0 | 0 | 0.00 | -35.91 | 0 | 0.2 | -3.82 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-570.40 | -477.5 | 0.02 | -57.3 | -43.6 | -1.95 | 0 | 0.22 | 7.23 | |||
| 469202 | LGND | LGND | 27.74 | 0.17 (0.62%) | 27.66 | 27.92 | 27.55 | 123K | 02/16/2013 | 21.96 | 0 | 0.00 | 0% | 26.32% | 0.00 | Add | Ligand Pharmaceuticals, Inc. | NAS(USA) | Drug Manufacturers - Specialty & Generic | 557.878 | 37.4 | 1.31 | 3.5 | 0.00 | 0 | 30.8 | 54.5 | 0.2 | 11.28 29.92 |
3.74 | 3.05 | 136.09 | 33.75 | 1.15 | 1442 | 2540.50 | 14.81 | 21.30 | 0.95 50 |
2.23 10 |
3.72 10 |
0 | 15.5 | -4.6 | -26.1 | 115.8 | 0 | 0 | 0.21 | 15.38 | 0 | 0 | 0.90 | -3.64 | 12.6 | 111.1 | 70.31 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
1.80 | -1.7 | -3.23 | -2 | -0.5 | -4.85 | 7 | -2.58 | -0.58 | ||
| 469203 | MDGN | MDGN | 4.15 | -0.03 (-0.72%) | 4.20 | 4.23 | 4.08 | 4.5K | 02/16/2013 | 5.06 | 0 | 0.00 | 0% | -17.98% | 0.00 | Add | Medgenics Inc | AMEX(USA) | Biotechnology | 77.2519 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0 | 3.66 16.43 |
-3.71 | 3.75 | -26.94 | -44.22 | 0 | 806 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0.00 | 0 | 0 | 21.7 | 0.00 |
Not Rated
Top Ranked Predictable Companies
|
0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| 469204 | SCLN | SCLN | 4.87 | 0.02 (0.41%) | 4.84 | 4.89 | 4.73 | 91.5K | 02/16/2013 | 4.97 | 0 | 0.00 | 0% | -2.01% | 0.00 | Add | SciClone Pharmaceuticals | NAS(USA) | Drug Manufacturers - Specialty & Generic | 262.277 | 156.27 | 2.65 | 0 | 0.00 | 0 | 80.8 | 52.9 | 66.8 | 3.68 7.58 |
-1.81 | 8.95 | -18.43 | 13 | 1.45 | 1177 | 30.40 | 1.82 | 1.80 | 6.32 50 |
0.67 10 |
0.82 10 |
0 | 16.9 | 23 | 18.8 | -71.4 | 0 | 0 | 0.64 | 10 | 2.62 | 0 | 3.50 | 2.97 | 29.5 | 28.6 | 18.86 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
4.10 | 6.2 | 0.99 | 6.7 | 5.5 | 5.86 | 5 | -4.12 | 0.53 | ||
| 469205 | SGEN | SGEN | 35.73 | -0.02 (-0.06%) | 35.78 | 36.20 | 35.50 | 450K | 02/16/2013 | 27.44 | 0 | 0.00 | 0% | 30.21% | 0.00 | Add | Seattle Genetics, Inc. | NAS(USA) | Biotechnology | 4335.25 | 219.9 | 1.88 | 0 | 0.00 | 0 | 88.5 | 38 | 10000 | 19.03 39 |
-7.34 | -3.33 | 66.73 | 54.21 | 1.02 | 2408 | 0.00 | 19.31 | 19.10 | 9.98 10 |
1.61 10 |
0 | 66.1 | 37 | 29.9 | 0 | -14.4 | -0.7 | 0.38 | 48.26 | 0 | 0 | 0.00 | -11 | 0 | 11.5 | -78.46 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-27.20 | -25.5 | 0.99 | -23.8 | -11.4 | 10.46 | 3 | -4.1 | 1.56 | |||
| 469206 | SPPI | SPPI | 8.13 | 0.08 (0.98%) | 8.07 | 8.16 | 8.03 | 664K | 02/16/2013 | 11.68 | 0 | 0.00 | 0% | -30.39% | 0.00 | Add | Spectrum Pharmaceuticals Inc | NAS(USA) | Biotechnology | 483.276 | 246.52 | 4.74 | 0 | 0.00 | 0 | 75.8 | 51.2 | 0 | 6.92 17.48 |
0.87 | 13.55 | -27.56 | -27.32 | 1.43 | 1222 | 11.35 | 2.08 | 1.70 | 7.25 50 |
0.67 10 |
0.54 10 |
0 | 12.8 | 53.2 | 69 | -10.1 | 0 | 0 | 1.25 | 28.01 | 5.22 | 0 | 13.00 | -0.43 | 0 | 7.7 | 6.33 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
29.80 | 35.3 | -1.3 | 33.2 | 18.7 | 2.1 | 4 | -2.53 | 0.33 | ||
| 469207 | SRPT | SRPT | 36.65 | -0.48 (-1.29%) | 37.01 | 37.41 | 35.27 | 1M | 02/16/2013 | 26.31 | 0 | 0.00 | 0% | 39.3% | 0.00 | Add | $SRPT: Focused on orphan drugs for Duchenne muscular dystrophy (DMD). JUst reported solid trial result for phase 11b drug candidate Etepirsen cooldecency99 (3 months ago) |
Sarepta Therapeutics Inc | NAS(USA) | Market Overview | 1184.8 | 30.59 | 3.89 | 0 | 0.00 | 0 | 61.2 | 38 | 10000 | 3.3 45 |
4.36 | 11.53 | 809.39 | 42.05 | 0 | 391 | 0.00 | 31.06 | 9.40 | 1.56 10 |
1.61 10 |
0 | -34.2 | 3.6 | 45.5 | 0 | -6.8 | -13.4 | 0.25 | 69.26 | 0 | 0 | 0.00 | -11.14 | 0 | 7.3 | -26.40 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-79.60 | -324.9 | 3.34 | -98.1 | -59.2 | 2.88 | 3 | -4.28 | 5.43 | ||
| 469209 | THRX | THRX | 37.52 | 0.51 (1.38%) | 37.14 | 38.17 | 37.00 | 1.3M | 02/16/2013 | 22.17 | 0 | 0.00 | 0% | 69.24% | 0.00 | Add | Theravance, Inc. | NAS(USA) | Biotechnology | 3680.78 | 10 | 1.58 | -1.98 | 0.00 | 0 | 53.8 | 42.1 | 0 | 17.06 42.41 |
-10.39 | 17.51 | 80.3 | 68.71 | 1.43 | 1408 | 0.00 | 357.14 | 23.60 | 5.66 10 |
0 | -93.1 | 28 | 7.9 | 0 | -46.5 | -30.6 | 0.05 | 6.91 | 0 | 0 | 0.00 | -42.93 | 0 | 16.9 | -31.44 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-9.60 | -13.7 | 0.37 | -12 | -5 | 2.15 | 3 | 222.93 | -0.09 | ||||
| 461840 | GILD | GILD | 56.47 | 0.73 (1.31%) | 56.14 | 56.85 | 55.76 | 10.1M | 02/03/2013 | 40.56 | 0 | 0.00 | 0% | 39.23% | 0.00 | Add | Gilead Sciences Inc | NAS(USA) | Biotechnology | 85023.3 | 9951.7 | 6.11 | 1.13 | 0.00 | 0 | 58.1 | 69.4 | 11.1 | 24.12 57.1 |
0.39 | 6.21 | 121.93 | 53.76 | 0.45 | 507 | 31.65 | 9.13 | 9.10 | 9.71 50 |
3.48 10 |
4.15 10 |
1.9 | 10 | 21.3 | 32.1 | 9.8 | 16.3 | 0 | 1.43 | 70.54 | 0 | 31.03 | 4.70 | 19.77 | 37.3 | 21.3 | 19.93 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
41.30 | 26.7 | -6.61 | 27.8 | 12.2 | 5.54 | 7 | -2.86 | -0.63 | ||
| 134810 | CYTX | CYTX | 2.54 | 0.04 (1.60%) | 2.51 | 2.58 | 2.50 | 207K | 05/01/2010 | 5.64 | 0 | 0.00 | 0% | -54.96% | 0.00 | Add | Conducting trial for its breast reconstruction technique. cooldecency99 (3 years ago) |
Cytori Therapeutics, Inc. | NAS(USA) | Biotechnology | 167.958 | 16.78 | 0.1 | 2.21 | 0.00 | 0 | 30.8 | 43 | 0 | 2.04 4.93 |
-9.29 | 2.42 | 18.14 | -9.29 | 1.92 | 2577 | 0.00 | 9.24 | 26.50 | 0 50 |
5.74 10 |
2.93 10 |
0 | 107.7 | -2.3 | -13.5 | 0 | -15 | -9 | 0.06 | 4.75 | 0 | 0 | 0.00 | -41.26 | 0 | 2.1 | -7.07 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-196.00 | -222.6 | -0.17 | -500.1 | -74.6 | -9.09 | 3 | -2.26 | -0.29 | |
| 134809 | EXAS | EXAS | 10.76 | 0.14 (1.32%) | 10.64 | 10.97 | 10.60 | 824K | 05/01/2010 | 4.44 | 0 | 0.00 | 0% | 142.34% | 0.00 | Add | Facing decision on the result of independent (Mayo Clinic) test of its colon cancer prep pack by 4th quarter. cooldecency99 (3 years ago) |
Exact Sciences Corporation | NAS(USA) | Biotechnology | 680.691 | 4.14 | 1.54 | 0.01 | 0.00 | 0 | 65.4 | 26.4 | 10000 | 6.93 12.3 |
4.98 | 16.58 | 5.91 | 1.61 | 1.36 | 879 | 0.00 | 158.73 | 6.90 | 0 21.2 |
8.84 10 |
1.49 10 |
0 | 0 | 0 | 0 | 0 | 28.9 | -6 | 0.03 | 3.02 | 0 | -21.5 | 0.00 | 22.91 | 0 | 1000 | -11.60 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-1270.30 | -1265 | 1.48 | -53.2 | -46.8 | 34.61 | 3 | 0 | 22.59 | |
| 134805 | KERX | KERX | 8.05 | 0.11 (1.39%) | 7.99 | 8.20 | 7.87 | 1.4M | 05/01/2010 | 5.59 | 0 | 0.00 | 0% | 44.01% | 0.00 | Add | In 2010 reported positive phase 2 trial result for its cancer drug candidate. cooldecency99 (3 years ago) |
Keryx Biopharmaceuticals, Inc. | NAS(USA) | Drug Manufacturers - Specialty & Generic | 648.841 | 7 | 0.46 | 0 | 0.00 | 0 | 0 | 0 | 10000 | 1.55 9.98 |
-4.96 | 0.25 | 352.25 | 207.25 | 0 | 261 | 0.00 | 84.03 | 17.50 | 0 23.71 |
1.1 10 |
1.87 10 |
0 | 520 | 103.6 | 0 | 0 | 0 | 0 | 0.01 | 3.34 | 0 | 0 | 0.00 | -9.7 | 0 | 7 | -263.69 |
Not Rated
Top Ranked Predictable Companies
|
-575.00 | -562.5 | 0.4 | -90.6 | -64.7 | 40.98 | 5 | -3.51 | 12.48 | |
| 134806 | PCYC | PCYC | 84.71 | 2.85 (3.48%) | 81.50 | 85.47 | 81.50 | 767K | 05/01/2010 | 7.59 | 0 | 0.00 | 0% | 1016.07% | 0.00 | Add | In 2010 reported positive phase 2 trail result for its cancer drug candidate. cooldecency99 (3 years ago) |
Pharmacyclics, Inc. | NAS(USA) | Drug Manufacturers - Specialty & Generic | 5958.02 | 184.65 | 1.87 | 0 | 0.00 | 0 | 92.3 | 63.6 | 10000 | 28.77 95.85 |
-3.89 | 9.28 | 170.81 | 46.61 | 1.06 | 327 | 61.35 | 34.01 | 45.30 | 35.9 50 |
0.26 10 |
0 | 29.8 | 235.1 | 18.1 | -153.1 | 0 | 0 | 0.08 | 84.46 | 2.6 | 0 | 0.10 | -0.67 | 0 | 1000 | 611.60 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
14.50 | 14.6 | 1.66 | 9.1 | 5.5 | 34.27 | 3 | 16.47 | 2.77 | ||
| 134808 | ONTY | ONTY | 2.00 | - | 2.02 | 2.05 | 1.98 | 1.3M | 05/01/2010 | 4.04 | 0 | 0.00 | 0% | -50.5% | 0.00 | Add | Facing decision on the result of its stage 3 trial cancer drug from partner Marck-Kgaa by 4th quarter. cooldecency99 (3 years ago) |
Oncothyreon, Inc. | NAS(USA) | Biotechnology | 114.432 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0 | 1.71 6.24 |
-21.26 | -17.01 | -42.69 | 4.17 | 0 | 1481 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.4 | 0.00 |
Not Rated
Top Ranked Predictable Companies
|
0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Summary | 0.22 (0.65%) | 0.00 | 57.42% | 0.00 | 127.39 | 367.17 | 10.46 | 127.39 | 367.17 | 10.46 |



RSS